NCT06185361

Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.

Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis. A Randomised Controlled Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Fayoum University Hospital · Academic / Other
• Sex: All
• Age: 8 Years – 16 Years
• Healthy volunteers: Not accepted

Summary

To determine whether there is a role for the selective serotonin reuptake inhibitors fluoxetine versus desmopressin in the treatment of nocturnal enuresis in children who have not responded to standard nonpharmacological urotherapy, and whether there are side effects involved.

Conditions

• Nocturnal Enuresis
• Enuresis
• Enuresis, Nocturnal

Interventions

Type	Name	Description
DRUG	Fluoxetine 20 MG	fluoxetine
DRUG	Desmopressin	desmopressin

Timeline

• Start date: 2022-12-01
• Primary completion: 2024-03-01
• Completion: 2024-03-01
• First posted: 2023-12-29
• Last updated: 2023-12-29

Locations

1 site across 1 country: Egypt